FI956209A - Hitaasti vapauttava täyteaine - Google Patents

Hitaasti vapauttava täyteaine Download PDF

Info

Publication number
FI956209A
FI956209A FI956209A FI956209A FI956209A FI 956209 A FI956209 A FI 956209A FI 956209 A FI956209 A FI 956209A FI 956209 A FI956209 A FI 956209A FI 956209 A FI956209 A FI 956209A
Authority
FI
Finland
Prior art keywords
slow release
release filler
cross
heteropolysaccharide
linking
Prior art date
Application number
FI956209A
Other languages
English (en)
Swedish (sv)
Other versions
FI956209A0 (fi
FI119353B (fi
Inventor
Anand R Baichwal
Troy W Mccall
Original Assignee
Mendell Co Inc Edward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendell Co Inc Edward filed Critical Mendell Co Inc Edward
Publication of FI956209A publication Critical patent/FI956209A/fi
Publication of FI956209A0 publication Critical patent/FI956209A0/fi
Application granted granted Critical
Publication of FI119353B publication Critical patent/FI119353B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Push-Button Switches (AREA)
  • Superstructure Of Vehicle (AREA)
  • Cosmetics (AREA)
FI956209A 1994-04-25 1995-12-22 Hitaasti vapauttava täyteaine FI119353B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25
US23262594 1994-04-25
PCT/US1995/003825 WO1995028916A1 (en) 1994-04-25 1995-03-21 Sustained release excipient
US9503825 1995-03-21

Publications (3)

Publication Number Publication Date
FI956209A true FI956209A (fi) 1995-12-22
FI956209A0 FI956209A0 (fi) 1995-12-22
FI119353B FI119353B (fi) 2008-10-31

Family

ID=22873888

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956209A FI119353B (fi) 1994-04-25 1995-12-22 Hitaasti vapauttava täyteaine

Country Status (18)

Country Link
EP (2) EP1145712B1 (fi)
JP (1) JP3279318B2 (fi)
KR (1) KR100232020B1 (fi)
CN (1) CN1131023C (fi)
AT (2) ATE308318T1 (fi)
AU (1) AU705378B2 (fi)
CA (1) CA2164513C (fi)
DE (2) DE69524358T2 (fi)
DK (1) DK0706377T3 (fi)
ES (2) ES2246961T3 (fi)
FI (1) FI119353B (fi)
HK (1) HK1040487B (fi)
HU (1) HU219818B (fi)
IL (1) IL113167A (fi)
MX (1) MX9600022A (fi)
PT (1) PT706377E (fi)
TW (1) TW357085B (fi)
WO (1) WO1995028916A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6783498A (en) 1997-04-04 1998-10-30 Monsanto Company Ph-selective delivery system using cross-linked polymeric resins as vehicles
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
AU6590598A (en) * 1997-04-04 1998-10-30 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
KR20030034171A (ko) 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
AU2002337686B2 (en) * 2001-09-26 2008-05-15 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
HUT73636A (en) 1996-08-28
ES2246961T3 (es) 2006-03-01
JPH08512061A (ja) 1996-12-17
WO1995028916A1 (en) 1995-11-02
KR100232020B1 (ko) 1999-12-01
DE69524358D1 (de) 2002-01-17
HK1040487A1 (en) 2002-06-14
ES2164764T3 (es) 2002-03-01
EP0706377A1 (en) 1996-04-17
EP0706377A4 (en) 1996-11-06
IL113167A0 (en) 1995-06-29
DE69534575D1 (de) 2005-12-08
EP1145712A1 (en) 2001-10-17
AU705378B2 (en) 1999-05-20
CN1127469A (zh) 1996-07-24
ATE308318T1 (de) 2005-11-15
EP0706377B1 (en) 2001-12-05
HU219818B (hu) 2001-08-28
HK1040487B (zh) 2006-05-12
KR960703016A (ko) 1996-06-19
JP3279318B2 (ja) 2002-04-30
MX9600022A (es) 1998-06-30
DE69534575T2 (de) 2006-07-13
DE69524358T2 (de) 2002-06-13
DK0706377T3 (da) 2002-04-02
EP1145712B1 (en) 2005-11-02
PT706377E (pt) 2002-05-31
HU9503456D0 (en) 1996-02-28
CA2164513A1 (en) 1995-11-02
AU2198295A (en) 1995-11-16
FI956209A0 (fi) 1995-12-22
TW357085B (en) 1999-05-01
CA2164513C (en) 1999-09-21
FI119353B (fi) 2008-10-31
ATE209906T1 (de) 2001-12-15
IL113167A (en) 2001-01-28
CN1131023C (zh) 2003-12-17

Similar Documents

Publication Publication Date Title
HUT75881A (en) Pharmaceutical composition for 24 hour release of metoprolol
SG28285A1 (en) Method for molding dental restorations and related apparatus
IL112637A0 (en) A pharmaceutical composition containing oxybutynin and methods for the preparation thereof
DE69523438D1 (de) Orale metoprolol-dosisform des typs "einmal täglich"
DK0480238T3 (da) Hydrofile aftryksmasser
EP0461586A3 (en) Dental composition for impression-taking
FI956209A (fi) Hitaasti vapauttava täyteaine
ES2024010B3 (es) Unidad de dosis farmaceutica.
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
DE3583780D1 (de) 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
HK1004549A1 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent central nervous system stimulant or sigma receptor agonist
ZA916570B (en) Desensitizing dental composition
ATA259590A (de) 3-(n-methyl-n-alkyl)-amino-2-methoxymethylenpro an-1-ol-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE2961713D1 (en) Organic diamine compounds for use as oral hypoglycemic agents and pharmaceutical compositions thereof
ATA252892A (de) Benzofuranylimidazolderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
FR2687068B1 (fr) Composition pour empreintes dentaires.
ITMI911450A1 (it) Endoapparecchio per il ripristino dell'articolazione coxofemorale
IT1235158B (it) Composizione farmaceutica a base di derivati carbazolici e metanolici nonche' impiego e confezione per essa
ITMI940515V0 (it) Dispositivo simmetropredeterminatore per la riproduzione del tracciato dell'arcata dentale
SE9300569D0 (sv) Apparat foer framstaellning av tandfyllningar

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119353

Country of ref document: FI

MM Patent lapsed